The Accommodation With Missing Data

The median red cells between the two groups was four and three units, about 40 percent in both groups got red cells. Even more similar was those that got plasma, which we just really didn't say a difference. I think the critical issue from this study is about the measurement of outcome. So we're very comfortable measuring mortality because it's very measurable. You don't miss it and it's obvious. There's no misclassification there, at least I hope not. But it's very difficult measuring in survivors' disability at what time, how long should we follow them up and everything. And it is a thing that somebody out here needs to fix.